Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT04273997) titled 'Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds' on Jan. 15, 2020.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: S.L.A. Pharma AG

Condition: Pilonidal Sinus

Intervention: Drug: Metronidazole 10% ointment

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2021

Target Sample Size: 80

Countries of Recruitment: Turkey

To know more, visit https://clinicaltrials.gov/show/NCT04273997

Published by H...